1. Home
  2. TOUR vs KPTI Comparison

TOUR vs KPTI Comparison

Compare TOUR & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TOUR
  • KPTI
  • Stock Information
  • Founded
  • TOUR 2006
  • KPTI 2008
  • Country
  • TOUR China
  • KPTI United States
  • Employees
  • TOUR N/A
  • KPTI N/A
  • Industry
  • TOUR Transportation Services
  • KPTI Biotechnology: Pharmaceutical Preparations
  • Sector
  • TOUR Consumer Discretionary
  • KPTI Health Care
  • Exchange
  • TOUR Nasdaq
  • KPTI Nasdaq
  • Market Cap
  • TOUR 97.8M
  • KPTI 102.4M
  • IPO Year
  • TOUR 2014
  • KPTI 2013
  • Fundamental
  • Price
  • TOUR $0.86
  • KPTI $5.20
  • Analyst Decision
  • TOUR
  • KPTI Strong Buy
  • Analyst Count
  • TOUR 0
  • KPTI 7
  • Target Price
  • TOUR N/A
  • KPTI $29.71
  • AVG Volume (30 Days)
  • TOUR 162.9K
  • KPTI 144.2K
  • Earning Date
  • TOUR 12-04-2025
  • KPTI 11-03-2025
  • Dividend Yield
  • TOUR 4.45%
  • KPTI N/A
  • EPS Growth
  • TOUR N/A
  • KPTI N/A
  • EPS
  • TOUR 0.03
  • KPTI N/A
  • Revenue
  • TOUR $75,532,120.00
  • KPTI $142,530,000.00
  • Revenue This Year
  • TOUR $12.27
  • KPTI $4.87
  • Revenue Next Year
  • TOUR $10.18
  • KPTI $9.20
  • P/E Ratio
  • TOUR $24.32
  • KPTI N/A
  • Revenue Growth
  • TOUR 7.57
  • KPTI N/A
  • 52 Week Low
  • TOUR $0.75
  • KPTI $3.51
  • 52 Week High
  • TOUR $1.18
  • KPTI $14.24
  • Technical
  • Relative Strength Index (RSI)
  • TOUR 50.07
  • KPTI 37.37
  • Support Level
  • TOUR $0.80
  • KPTI $6.09
  • Resistance Level
  • TOUR $0.86
  • KPTI $6.17
  • Average True Range (ATR)
  • TOUR 0.03
  • KPTI 0.41
  • MACD
  • TOUR 0.00
  • KPTI -0.10
  • Stochastic Oscillator
  • TOUR 80.89
  • KPTI 15.00

About TOUR Tuniu Corporation

Tuniu Corp is an online leisure travel company. The company is engaged in the provision of travel-related services in the People's Republic of China. It offers a large selection of packaged tours, including organized tours and self-guided tours, as well as travel-related services for leisure travelers. The company's organized tours provide pre-arranged itineraries, transportation, accommodations, entertainment, meals, and tour guide services. Its self-guided tours consist of combinations of flights and hotel bookings and other optional add-ons. The company derives almost all of its revenue from PRC.

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company derives its revenue from United States.

Share on Social Networks: